![](/img/cover-not-exists.png)
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study
John R Teerlink, Cyril P Clarke, Khalil G Saikali, Jacqueline H Lee, Michael M Chen, Rafael D Escandon, Lyndsey Elliott, Rachel Bee, Mohammad Reza Habibzadeh, Jonathan H Goldman, Nelson B Schiller, FaVolume:
378
Year:
2011
Language:
english
DOI:
10.1016/s0140-6736(11)61219-1
File:
PDF, 229 KB
english, 2011